Back to Search
Start Over
Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team
- Source :
- HIV clinical trials. 19(1)
- Publication Year :
- 2017
-
Abstract
- OBJECTIVES: Interactions between antiretroviral treatment (ART) and comedications are a concern in HIV-infected patients. This study aimed to determine the frequency and severity of potential drug-drug interactions (PDDIs) with ART in our setting. METHODS: Observational study by a multidisciplinary team in 1259 consecutive HIV patients (March 2015-September 2016). Data on demographics, toxic habits, comorbidities, and current ART were collected. A structured questionnaire recorded concomitant medications (including occasional and over-the-counter drugs). PDDIs were classified into four categories: (1) no interactions, (2) mild (clinically non-significant), (3) moderate (requiring close monitoring or drug modification/dose adjustment), and (4) severe (contraindicated). STATISTICAL ANALYSIS: chi-square test, logistic regression analysis. RESULTS: In total, 881 (70%) patients took comedication, and 563 (44.7%) had ≥ PDDI. Forty-one comedicated patients (4.6%) had severe and 522 (59.2%) moderate PDDIs. Moderate PDDIs mainly involved cardiovascular (53.8%) and central nervous system (40.2%) drugs. Independent risk factors for PDDIs were ART containing a boosted protease inhibitor (odds ratio [OR]=9.11, 95% confidence interval [CI] 5.15-16.11; p = 0.0001) and/or non-nucleoside reverse transcriptase (NNRTI) (OR = 4.34, 95%CI 2.49-7.55; p = 0.0001), HCV co-infection (OR = 3.26, 95%CI 2.15-4.93; p = 0.0001), and use of two or more comedications (OR = 3.36, 95%CI 2.27-4.97; p = 0.0001). Adherence and effectiveness of ART were similar in patients with and without PDDIs. The team made 133 recommendations related to comedications (drug change or dose adjustment) or ART (drug switch or change in administration schedule). CONCLUSIONS: Systematic evaluation detected a significant percentage of PDDIs requiring an intervention in HIV patients on ART. Monitoring and advice about drug-drug interactions should be part of routine practice.
- Subjects :
- Drug–drug interactions
0301 basic medicine
Drug
Adult
Male
medicine.medical_specialty
Anti-HIV Agents
media_common.quotation_subject
030106 microbiology
Interdisciplinary Research
Human immunodeficiency virus (HIV)
HIV Infections
macromolecular substances
medicine.disease_cause
Multidisciplinary team
Cohort Studies
03 medical and health sciences
Highly active antiretroviral therapy
0302 clinical medicine
Acquired immunodeficiency syndrome (AIDS)
Risk Factors
Internal medicine
VIH (Virus)
medicine
Antiretroviral treatment
Hiv infected patients
Humans
Pharmacology (medical)
Drug Interactions
030212 general & internal medicine
Concomitant medications
media_common
business.industry
HIV
Sida -- Tractament
Middle Aged
medicine.disease
Medicaments -- Interacció
AIDS
Infectious Diseases
Cohort
Physical therapy
Drug Therapy, Combination
Female
business
Cohort study
Subjects
Details
- ISSN :
- 19455771
- Volume :
- 19
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- HIV clinical trials
- Accession number :
- edsair.doi.dedup.....9978db2dd60ac937c9f4ef28221afd6d